The relationship between serum progesterone level on the day of HCG trigger in IVF/ICSI cycles and oocyte maturation and embryo quality: a retrospective observational study
- PMID: 39736583
- PMCID: PMC11684037
- DOI: 10.1186/s12905-024-03535-9
The relationship between serum progesterone level on the day of HCG trigger in IVF/ICSI cycles and oocyte maturation and embryo quality: a retrospective observational study
Abstract
Purpose: Previous studies have suggested a link between serum progesterone levels on the day of the HCG trigger in IVF cycles and oocyte and embryo quality. This study aims to explore this relationship more thoroughly.
Methods: This study included 496 infertility patients at Moloud Infertility Treatment Center, Zahedan, Iran. Statistical methods were used to assess factors such as oocyte maturation and embryo quality, fertilization rate, BMI, and gonadotropin dosage.
Results: While an initial progesterone cutoff of 1.2 ng/ml was used to perform fundamental analysis, a more accurate cutoff of 1.54 ng/ml was identified, beyond which the average number of M1 oocytes significantly declined. A strong relationship was found between higher progesterone levels and a greater number of retrieved oocytes (p = 0.004), with M1 oocytes showing a similar relation. Also, BMI was significantly related to the quality of eight-cell grade B embryos (p = 0.006). However, no significant correlations were found between progesterone levels and other factors, including patient age (p = 0.327), fertilization rate (p = 0.603), or embryo quality at other stages.
Conclusions: The findings demonstrate that elevated progesterone level, particularly beyond the identified cutoff of 1.54 ng/ml, is a valuable clinical indicator of suboptimal IVF outcomes due to its negative impact on oocyte maturation.
Keywords: Embryo quality; HCG trigger; IVF; Infertility; Oocyte maturation; Progesterone.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Ethical approval: The studies involving human participants were reviewed and approved by the Zahedan University of Medical Sciences Ethics Committee and were conducted according to the guidelines on human experimentation of the 1975 Declaration of Helsinki. The patients/participants provided their written informed consent to participate in this study. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
Dual trigger for final oocyte maturation improves the oocyte retrieval rate of suboptimal responders to gonadotropin-releasing hormone agonist.Fertil Steril. 2016 Nov;106(6):1356-1362. doi: 10.1016/j.fertnstert.2016.07.1068. Epub 2016 Aug 1. Fertil Steril. 2016. PMID: 27490046
-
GnRH agonist versus HCG triggering in different IVF/ICSI cycles of same patients: a retrospective study.J Obstet Gynaecol. 2020 Aug;40(6):837-842. doi: 10.1080/01443615.2019.1674262. Epub 2019 Dec 3. J Obstet Gynaecol. 2020. PMID: 31791167
-
Analysis of IVF/ICSI-FET Outcomes in Women With Advanced Endometriosis: Influence on Ovarian Response and Oocyte Competence.Front Endocrinol (Lausanne). 2020 Jul 17;11:427. doi: 10.3389/fendo.2020.00427. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32765424 Free PMC article.
-
Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10,000 cycles.Fertil Steril. 2012 Jun;97(6):1321-7.e1-4. doi: 10.1016/j.fertnstert.2012.03.014. Epub 2012 Apr 10. Fertil Steril. 2012. PMID: 22494924
-
Timing of human chorionic gonadotropin (hCG) hormone administration in IVF/ICSI protocols using GnRH agonist or antagonists: a systematic review and meta-analysis.Gynecol Endocrinol. 2014 Jun;30(6):431-7. doi: 10.3109/09513590.2014.895984. Epub 2014 Apr 14. Gynecol Endocrinol. 2014. PMID: 24731070
References
-
- Allen C, McLernon D, Bhattacharya S, Maheshwari A. Early pregnancy outcomes of IVF cycles using donor versus partner sperm: analysis of 1,376,454 cycles recorded by the Human Fertilisation and Embryology Authority (1991–2016). Hum Reprod. 2023;38(6):1194–201. - PubMed
-
- Mahran A, Khairy M, Elkhateeb R, Hegazy AR, Abdelmeged A, Batiha GE, et al. The value of serum progesterone level on the day of human chorionic gonadotropin administration/metaphase II oocyte ratio in predicting IVF/ICSI outcome in patients with normal ovarian reserve. J Ovarian Res. 2021;14(1):52. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources